HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria E Fernandez Selected Research

Colorectal Neoplasms (Colorectal Cancer)

1/2023Using cognitive interviews to improve a measure of organizational readiness for implementation.
1/2023Examining readiness for implementing practice changes in federally qualified health centers: A rapid qualitative study.
1/2022Applying evidence-based intervention (EBI) mapping to identify the components and logic of colorectal cancer screening interventions.
1/2022Using Implementation Mapping to Develop Implementation Strategies for the Delivery of a Cancer Prevention and Control Phone Navigation Program: A Collaboration With 2-1-1.
3/2017Impact of the Cancer Prevention and Control Research Network: Accelerating the Translation of Research Into Practice.
5/2012Cancer control needs of 2-1-1 callers in Missouri, North Carolina, Texas, and Washington.
4/2008Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria E Fernandez Research Topics

Disease

9Neoplasms (Cancer)
12/2023 - 05/2012
7Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 04/2008
5Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2015 - 11/2009
2Sickle Cell Anemia (Hemoglobin S Disease)
12/2023 - 07/2020
2COVID-19
01/2023 - 01/2021
1Weight Loss (Weight Reduction)
03/2024
1Whooping Cough (Pertussis)
11/2022
1Tetanus
11/2022
1Diphtheria
11/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Anus Neoplasms (Anal Cancer)
01/2021
1Acute Disease
07/2020
1Body Weight (Weight, Body)
06/2019

Drug/Important Bio-Agent (IBA)

6VaccinesIBA
01/2023 - 11/2009
4ethylenebis(isothiocyanate) (EBIS)IBA
12/2023 - 12/2018
4Calcibiotic Root Canal SealerIBA
01/2023 - 04/2008
3Papillomavirus Vaccines (HPV Vaccines)IBA
01/2020 - 11/2009
2Hydroxyurea (Hydrea)FDA LinkGeneric
12/2023 - 07/2020
14-nitro-3-dimethylaminopropiophenoneIBA
03/2024
1ToxoidsIBA
11/2022
1cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2022
1AnticoagulantsIBA
01/2021
1ThymolIBA
06/2019
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
06/2019
1Fatty Acids (Saturated Fatty Acids)IBA
06/2019
1Aligeron (AS 2)IBA
03/2017
1Biomarkers (Surrogate Marker)IBA
03/2014
1SmokeIBA
05/2012

Therapy/Procedure

2Behavior Control
10/2015 - 01/2013
1Chemoprevention
01/2022
1Therapeutics
07/2020
1Aftercare (After-Treatment)
11/2015